annual D&A:
$317.00K+$20.00K(+6.73%)Summary
- As of today (July 11, 2025), ELVN annual depreciation & amortization is $317.00 thousand, with the most recent change of +$20.00 thousand (+6.73%) on December 31, 2024.
- During the last 3 years, ELVN annual D&A has risen by +$202.00 thousand (+175.65%).
- ELVN annual D&A is now at all-time high.
Performance
ELVN Depreciation and amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly D&A:
$74.00K-$6000.00(-7.50%)Summary
- As of today (July 11, 2025), ELVN quarterly depreciation & amortization is $74.00 thousand, with the most recent change of -$6000.00 (-7.50%) on March 31, 2025.
- Over the past year, ELVN quarterly D&A has dropped by -$5000.00 (-6.33%).
- ELVN quarterly D&A is now -7.50% below its all-time high of $80.00 thousand, reached on September 30, 2024.
Performance
ELVN quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM D&A:
$312.00K-$5000.00(-1.58%)Summary
- As of today (July 11, 2025), ELVN TTM depreciation & amortization is $312.00 thousand, with the most recent change of -$5000.00 (-1.58%) on March 31, 2025.
- Over the past year, ELVN TTM D&A has increased by +$3000.00 (+0.97%).
- ELVN TTM D&A is now -1.58% below its all-time high of $317.00 thousand, reached on December 31, 2024.
Performance
ELVN TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
ELVN Depreciation and amortization Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +6.7% | -6.3% | +1.0% |
| 3 y3 years | +175.7% | +89.7% | +700.0% |
| 5 y5 years | +604.4% | - | - |
ELVN Depreciation and amortization Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +175.7% | -7.5% | +42.3% | -1.6% | +242.9% |
| 5 y | 5-year | at high | +604.4% | -7.5% | +89.7% | -1.6% | +700.0% |
| alltime | all time | at high | +604.4% | -7.5% | +89.7% | -1.6% | +700.0% |
ELVN Depreciation and amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $74.00K(-7.5%) | $312.00K(-1.6%) |
| Dec 2024 | $317.00K(+6.7%) | $80.00K(0.0%) | $317.00K(+0.6%) |
| Sep 2024 | - | $80.00K(+2.6%) | $315.00K(+0.6%) |
| Jun 2024 | - | $78.00K(-1.3%) | $313.00K(+1.3%) |
| Mar 2024 | - | $79.00K(+1.3%) | $309.00K(+4.0%) |
| Dec 2023 | $297.00K | $78.00K(0.0%) | $297.00K(+4.9%) |
| Sep 2023 | - | $78.00K(+5.4%) | $283.00K(+6.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2023 | - | $74.00K(+10.4%) | $265.00K(+9.1%) |
| Mar 2023 | - | $67.00K(+4.7%) | $243.00K(+13.0%) |
| Dec 2022 | $215.00K(+87.0%) | $64.00K(+6.7%) | $215.00K(+42.4%) |
| Sep 2022 | - | $60.00K(+15.4%) | $151.00K(+65.9%) |
| Jun 2022 | - | $52.00K(+33.3%) | $91.00K(+133.3%) |
| Mar 2022 | - | $39.00K | $39.00K |
| Dec 2021 | $115.00K(+155.6%) | - | - |
| Dec 2020 | $45.00K | - | - |
FAQ
- What is Enliven Therapeutics, Inc. annual depreciation & amortization?
- What is the all time high annual D&A for Enliven Therapeutics, Inc.?
- What is Enliven Therapeutics, Inc. annual D&A year-on-year change?
- What is Enliven Therapeutics, Inc. quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Enliven Therapeutics, Inc.?
- What is Enliven Therapeutics, Inc. quarterly D&A year-on-year change?
- What is Enliven Therapeutics, Inc. TTM depreciation & amortization?
- What is the all time high TTM D&A for Enliven Therapeutics, Inc.?
- What is Enliven Therapeutics, Inc. TTM D&A year-on-year change?
What is Enliven Therapeutics, Inc. annual depreciation & amortization?
The current annual D&A of ELVN is $317.00K
What is the all time high annual D&A for Enliven Therapeutics, Inc.?
Enliven Therapeutics, Inc. all-time high annual depreciation & amortization is $317.00K
What is Enliven Therapeutics, Inc. annual D&A year-on-year change?
Over the past year, ELVN annual depreciation & amortization has changed by +$20.00K (+6.73%)
What is Enliven Therapeutics, Inc. quarterly depreciation & amortization?
The current quarterly D&A of ELVN is $74.00K
What is the all time high quarterly D&A for Enliven Therapeutics, Inc.?
Enliven Therapeutics, Inc. all-time high quarterly depreciation & amortization is $80.00K
What is Enliven Therapeutics, Inc. quarterly D&A year-on-year change?
Over the past year, ELVN quarterly depreciation & amortization has changed by -$5000.00 (-6.33%)
What is Enliven Therapeutics, Inc. TTM depreciation & amortization?
The current TTM D&A of ELVN is $312.00K
What is the all time high TTM D&A for Enliven Therapeutics, Inc.?
Enliven Therapeutics, Inc. all-time high TTM depreciation & amortization is $317.00K
What is Enliven Therapeutics, Inc. TTM D&A year-on-year change?
Over the past year, ELVN TTM depreciation & amortization has changed by +$3000.00 (+0.97%)